Condition
Recurrent Pregnancy Losses
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Terminated1
Completed1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01688284Not ApplicableTerminatedPrimary
The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage
NCT00456118CompletedPrimary
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
NCT01661439UnknownPrimary
Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
Showing all 3 trials